一例摄入胶体银后发生银质沉着病的病例。
A case of argyria after colloidal silver ingestion.
作者信息
Chang Anne Lynn S, Khosravi Vista, Egbert Barbara
机构信息
Department of Dermatology, Stanford University Medical Center, Stanford, CA 94305, USA.
出版信息
J Cutan Pathol. 2006 Dec;33(12):809-11. doi: 10.1111/j.1600-0560.2006.00557.x.
BACKGROUND
Argyria is often considered an entity of the past, one which has largely disappeared with the cessation of silver usage in oral medications. However, with the practice of colloidal silver ingestion in current "alternative health" treatments, argyria should be considered in the differential diagnosis of blue-gray hyperpigmentation.
METHODS
A single case report with clinicopathological correlation.
RESULTS
Histological examination of skin biopsy specimen, which showed perieccrine brown-black granules, verified that colloidal silver rather than a prescribed medication was the source of the patient's dyspigmentation.
背景
银质沉着症通常被认为是过去的一种病症，随着口服药物中停止使用银，这种病症在很大程度上已消失。然而，鉴于当前“替代健康”疗法中存在摄入胶体银的情况，在对蓝灰色色素沉着进行鉴别诊断时应考虑银质沉着症。
方法
一份伴有临床病理相关性的单病例报告。
结果
皮肤活检标本的组织学检查显示汗腺周围有棕黑色颗粒，证实胶体银而非处方药是患者色素沉着异常的根源。
Zotero 插件